149 related articles for article (PubMed ID: 11902219)
1. Lotronex(tm): therapy for diarrhea predominant irritable bowel syndrome.
McGahan L
Issues Emerg Health Technol; 2000 Oct; (11):1-5. PubMed ID: 11902219
[No Abstract] [Full Text] [Related]
2. Contemporary thoughts on the treatment of irritable bowel syndrome.
Giaquinta D
Manag Care Interface; 2002 Aug; 15(8):19-20, 22. PubMed ID: 12229060
[No Abstract] [Full Text] [Related]
3. Alosetron (Lotronex) for treatment of irritable bowel syndrome.
Med Lett Drugs Ther; 2000 Jun; 42(1081):53-4. PubMed ID: 10872030
[No Abstract] [Full Text] [Related]
4. New drugs to treat irritable bowel syndrome being tested.
Mayo Clin Health Lett; 2000 Mar; 18(3):4. PubMed ID: 10734837
[No Abstract] [Full Text] [Related]
5. [New therapeutic approaches in irritable bowel syndrome].
Müller-Lissner SA
Z Gastroenterol; 2000 Sep; 38(9):815-6. PubMed ID: 11072681
[No Abstract] [Full Text] [Related]
6. So what happened to alosetron?
Hyams JS
J Pediatr Gastroenterol Nutr; 2001 May; 32(5):513-4. PubMed ID: 11455947
[No Abstract] [Full Text] [Related]
7. Novel medications for the irritable bowel syndrome: motility and sensation.
Camilleri M
J Pediatr Gastroenterol Nutr; 2001; 32 Suppl 1():S35-7. PubMed ID: 11321419
[No Abstract] [Full Text] [Related]
8. Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome.
Chey WD; Chey WY; Heath AT; Dukes GE; Carter EG; Northcutt A; Ameen VZ
Am J Gastroenterol; 2004 Nov; 99(11):2195-203. PubMed ID: 15555002
[TBL] [Abstract][Full Text] [Related]
9. Irritable bowel syndrome. A poorly understood disorder.
Lewis C
FDA Consum; 2001; 35(4):30-6. PubMed ID: 11692885
[No Abstract] [Full Text] [Related]
10. Tolerability and safety of alosetron during long-term administration in female and male irritable bowel syndrome patients.
Wolfe SG; Chey WY; Washington MK; Harding J; Heath AT; McSorley DJ; Dukes GE; Hunt CM
Am J Gastroenterol; 2001 Mar; 96(3):803-11. PubMed ID: 11280555
[TBL] [Abstract][Full Text] [Related]
11. Alosetron (Lotronex) is back: should I use it to treat my patients with irritable bowel syndrome?
Shen B; Soffer EE
Cleve Clin J Med; 2003 Jan; 70(1):64-5. PubMed ID: 12549728
[No Abstract] [Full Text] [Related]
12. Alosetron for severe diarrhea-predominant irritable bowel syndrome: safety and efficacy in perspective.
Lewis JH
Expert Rev Gastroenterol Hepatol; 2010 Feb; 4(1):13-29. PubMed ID: 20136586
[TBL] [Abstract][Full Text] [Related]
13. Drug for irritable bowel syndrome taken off the market.
Charatan F
BMJ; 2000 Dec; 321(7274):1429. PubMed ID: 11228674
[No Abstract] [Full Text] [Related]
14. [Soon one "female distress" less. Irritable bowel syndrome responds to serotonin blockers].
MMW Fortschr Med; 2000 Sep; 142(37):55. PubMed ID: 11026224
[No Abstract] [Full Text] [Related]
15. Patient satisfaction with alosetron for the treatment of women with diarrhea-predominant irritable bowel syndrome.
Olden K; DeGarmo RG; Jhingran P; Bagby B; Decker C; Markowitz M; Carter E; Bobbitt W; Dahdul A; DeCastro E; Gringeri L; Johanson J; Levinson L; Mula G; Poleynard G; Stoltz RR; Truesdale R; Young D;
Am J Gastroenterol; 2002 Dec; 97(12):3139-46. PubMed ID: 12492201
[TBL] [Abstract][Full Text] [Related]
16. Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome.
Watson ME; Lacey L; Kong S; Northcutt AR; McSorley D; Hahn B; Mangel AW
Am J Gastroenterol; 2001 Feb; 96(2):455-9. PubMed ID: 11232690
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics and functional gastrointestinal disorders.
Camilleri M
Pharmacogenomics; 2005 Jul; 6(5):491-501. PubMed ID: 16013999
[TBL] [Abstract][Full Text] [Related]
18. Irritable bowel syndrome. New treatment drug on the market.
Harv Health Lett; 2000 Jun; 25(8):7. PubMed ID: 10810051
[No Abstract] [Full Text] [Related]
19. FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.
Horwitz BJ
Health News; 2002 Oct; 8(10):1-2. PubMed ID: 12416480
[No Abstract] [Full Text] [Related]
20. Tegaserod and other serotonergic agents: what is the evidence?
Chey WD
Rev Gastroenterol Disord; 2003; 3 Suppl 2():S35-40. PubMed ID: 12776001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
